Recombinomics | Elegant Evolution






Home Founder What's New In The News Contact Us





























Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Patents

Recombinomics, Inc. Founder and President Henry L Niman, PhD has filed patents covering use of viral recombination in:

vaccine development
genetic stability monitoring
bio-informatics
basic applications of the genetics of rapid evolution

20090232842 Indentifying and Predicting Infleunza Variants and Uses Thereof

20070253978 Copy Choice Recombination and Uses Thereof

WO/2008/091659 Methods and Compositions for Predicting and Treating Drug Resistant Strains of Influenza Virus
PCT/US2008/00923

WO/2007/008605 Identifying and Predicting Influenza Variants and Uses Thereof
PCT/US2006/026354

WO/2006/033691 A2 Copy Choice Recombination and Uses Thereof
PCT/US2005/022873

Dr. Niman has been issued patents covering:

coupling monoclonal antibody and synthetic peptide technologies
protein expression profiling

Issued United States Patents

6,551,789    Process for characterizing a biological sample using patterns of oncogene expression

5,985,587    Polypeptide-induced monoclonal receptors to protein ligands

5,972,629    Method for characterizing antigenic reactivity of biological sample

5,786,178    Polypeptide-induced monoclonal receptors to protein ligands

5,733,738    Polypeptide-induced monoclonal receptors to protein ligands

5,591,587    Polypeptide-induced monoclonal receptors to protein ligands

5,563,247    Monoclonal antibodies to oncoproteins and methods of making monoclonal antibodies

5,030,565    Polypeptide-induced monoclonal receptors to protein ligands

5,015,571    Polypeptide-induced monoclonal receptors to protein ligands















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2007 Recombinomics.  All rights reserved.